MENT, short for 7-alpha-methyl-19-nortestosterone (also called trestolone), is a synthetic anabolic-androgenic steroid originally developed as a potential male contraceptive and treatment for age-related hormone decline. It belongs to the 19-nor family of steroids, meaning its chemical structure is similar to testosterone but with a specific carbon atom removed and a methyl group added. These modifications make it significantly more potent than testosterone on a milligram-for-milligram basis.
How MENT Works in the Body
MENT activates the same androgen receptors that testosterone does, driving muscle protein synthesis, bone density maintenance, and the other effects associated with male hormones. What sets it apart is potency: it binds to androgen receptors with considerably greater strength than testosterone, so smaller doses produce pronounced anabolic effects.
Like testosterone, MENT undergoes aromatization, the enzymatic process that converts androgens into estrogen. In MENT’s case, the conversion produces a unique estrogen called 7-alpha-methyl-estradiol. This means users can still experience estrogen-related side effects such as water retention and breast tissue growth, sometimes to a greater degree than with testosterone because of MENT’s high potency. The aromatization also means MENT can support functions that require some estrogen, like maintaining healthy cholesterol metabolism and bone mineral density.
One notable biological feature is that MENT does not appear to be converted by the enzyme 5-alpha reductase into a more potent form the way testosterone converts into DHT. This theoretically reduces certain androgenic side effects like hair loss and prostate enlargement, though it does not eliminate androgenic activity entirely since MENT itself is already a strong androgen.
Why It Was Developed
MENT was originally investigated as a male hormonal contraceptive. It powerfully suppresses the release of two pituitary hormones, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential for sperm production. By shutting down these signals, MENT impairs spermatogenesis to a degree that researchers believed could provide reliable birth control for men. At the same time, its androgenic activity would theoretically prevent the muscle loss, fatigue, and low libido that come with simply suppressing natural testosterone.
Trestolone also reached Phase II clinical trials as a treatment for andropause, the gradual decline in testosterone that occurs in aging men. The idea was that MENT could serve as a hormone replacement option, delivering strong androgenic support without stimulating prostate growth as aggressively as testosterone or DHT. However, neither the contraceptive nor the hormone replacement application has resulted in an approved pharmaceutical product. MENT remains an experimental compound with no regulatory approval for medical use in any country.
MENT in Performance Enhancement
Despite its experimental status, MENT has gained a following in bodybuilding and performance enhancement circles. Users report rapid gains in muscle mass and strength, often describing it as one of the most powerful injectable steroids available. Its high anabolic potency means that doses measured in micrograms or low milligrams can produce effects that would require much larger amounts of testosterone.
The compound is most commonly available as trestolone acetate, an ester form that controls how quickly the drug is released after injection. The acetate ester is short-acting, which means frequent injections (often daily) are typical. Some users prefer this because blood levels can be adjusted quickly if side effects appear, but it also makes the administration schedule more demanding than longer-acting steroids.
Estrogen management is one of the biggest practical challenges with MENT. Because it aromatizes into 7-alpha-methyl-estradiol rather than regular estradiol, standard blood tests for estrogen may not accurately reflect estrogenic activity. Users often report high-estrogen symptoms like bloating, mood changes, and gynecomastia even when lab work appears normal. The typical aromatase inhibitors used alongside other steroids may also behave differently with MENT’s unique estrogen metabolite, making dose management less predictable.
Side Effects and Risks
MENT carries the same broad category of risks as other anabolic steroids, along with some that are specific to its chemistry. Suppression of natural testosterone production is virtually guaranteed and tends to be deep and rapid. Recovery of the body’s own hormone production after discontinuation can be prolonged and difficult, particularly after extended use.
Cardiovascular effects are a serious concern. Like other anabolic steroids, MENT can negatively shift cholesterol levels by lowering HDL (protective cholesterol) and raising LDL. It can also increase blood pressure, partly through estrogen-driven water retention and partly through direct vascular effects. These changes raise the long-term risk of heart disease.
Other reported side effects include:
- Gynecomastia: Breast tissue development from estrogenic activity, which can be difficult to manage because of the atypical estrogen MENT produces
- Mood changes: Irritability, anxiety, or emotional instability, often linked to fluctuating estrogen levels
- Sleep disruption: Insomnia or night sweats, commonly reported at higher doses
- Skin effects: Acne and oily skin, though potentially less severe than with highly androgenic compounds
- Liver stress: Generally considered lower risk than oral steroids since MENT is typically injected, but not zero
Because MENT has never completed the full clinical trial process, long-term safety data in humans is extremely limited. Most of what is known about its effects at the doses used for physique enhancement comes from user reports rather than controlled studies, which means the true risk profile remains unclear.
How MENT Compares to Testosterone
The simplest way to think about MENT is as a much stronger version of testosterone with a different estrogen profile. Where testosterone might be used at 200 to 500 milligrams per week for performance purposes, MENT users often report meaningful effects at a fraction of that dose. This higher potency per milligram does not mean it is safer; it means the margin for error in dosing is smaller.
The key differences come down to three areas. First, MENT does not convert to DHT, which may spare the prostate and hair follicles to some extent. Second, its estrogen metabolite is different from the estradiol produced by testosterone, making estrogen management less straightforward. Third, its suppressive effect on the pituitary is more aggressive, which can make post-cycle recovery harder than with testosterone alone.
For all its potency, MENT occupies a gray area: too experimental for mainstream medicine, too powerful and unpredictable for casual use, and lacking the decades of clinical data that even testosterone has accumulated. Anyone encountering MENT should understand that its impressive anabolic reputation comes with a correspondingly high level of uncertainty about its long-term consequences.